What laboratory panel should be ordered to evaluate for tick-borne infections?

Laboratory Panel for Tick-Borne Infections

Order paired acute and convalescent serology (IFA) collected 2–4 weeks apart as the reference standard, but initiate empiric treatment immediately based on clinical suspicion without waiting for results, and add PCR on whole blood during the first week for ehrlichiosis/anaplasmosis, plus blood smear microscopy for morulae when available. 1, 2

Immediate Diagnostic Approach (First Week of Illness)

Core Laboratory Tests to Order

Serology (Acute-Phase Specimen)

• Draw IFA (indirect immunofluorescence antibody) assay for Rickettsia rickettsii, Anaplasma phagocytophilum, Ehrlichia chaffeensis, and Babesia microti during the first week of illness, recognizing this will likely be negative but is essential for paired testing later 1, 2
• A negative acute-phase serology does not exclude tick-borne disease and should never delay treatment 1, 2
• Single elevated titers are meaningless—5–10% of the general U.S. population has detectable R. rickettsii antibodies at titers ≥1:64 without active disease 2

Molecular Testing (PCR)

• Order PCR on whole blood for Anaplasma phagocytophilum and Ehrlichia species during the acute phase—this is highly sensitive for ehrlichiosis and anaplasmosis 1
• PCR for Rocky Mountain spotted fever (RMSF) is less sensitive from whole blood but increases in severe disease; consider PCR from skin biopsy of rash or eschar if present 1
• For Lyme disease, PCR on whole blood has limited utility; serology remains the primary diagnostic method 3

Blood Smear Microscopy

• Examine thick and thin blood smears or concentrated buffy-coat preparation for morulae (intracellular inclusions) in leukocytes—highly specific for anaplasmosis or ehrlichiosis when present 1
• Blood smear is not useful for RMSF or other spotted fever group rickettsioses 1
• Morulae are found in only a minority of cases and require experienced microscopists to distinguish from platelets, Döhle bodies, and other cytoplasmic inclusions 1

Additional Considerations for Specific Pathogens

Babesiosis

• Blood smear for intraerythrocytic parasites (ring forms, tetrads/"Maltese cross") 4
• PCR for Babesia microti on whole blood 5

Lyme Disease

• Two-tier serology (ELISA followed by Western blot) is standard, but antibodies typically absent in first 2–3 weeks 3, 4
• Do not order Lyme serology in isolation for acute febrile illness without erythema migrans 3

Confirmatory Testing (2–4 Weeks Later)

Convalescent Serology

Timing and Interpretation

• Collect convalescent specimen 2–4 weeks after the acute draw for rickettsial diseases, ehrlichioses, and anaplasmosis 1, 2
• Both acute and convalescent specimens must be tested simultaneously in the same assay run to eliminate inter-assay variation 2
• A ≥4-fold rise in IgG titer (e.g., 1:64 → 1:256) confirms acute infection when clinical presentation is compatible 1, 2
• This two-dilution difference exceeds normal assay variability and provides high specificity 2

Critical Pitfall

• Antibodies persist long after recovery: R. rickettsii IgG remains detectable >1 year, A. phagocytophilum antibodies may persist >4 years 2
• A single high titer without documented rise is not diagnostic and may reflect prior exposure 2

Treatment Decision-Making

Do Not Wait for Laboratory Confirmation

Empiric Therapy Protocol

• Start doxycycline immediately for suspected RMSF, ehrlichiosis, or anaplasmosis based on fever, headache, myalgia, and tick exposure in endemic areas 1
• Delay in doxycycline therapy for RMSF increases mortality risk dramatically 1
• Early doxycycline does not prevent seroconversion or blunt antibody response, so proceed with paired serology regardless 2

When to Suspect Tick-Borne Disease

• Fever + headache + myalgia in tick-endemic area during spring/summer months 1, 4
• Rash (maculopapular, petechial, or erythema migrans) 1, 4
• Thrombocytopenia, leukopenia, or elevated transaminases on routine labs 1, 4
• Recent tick bite (though many patients do not recall a bite) 3, 1

Multiplex and Emerging Diagnostic Platforms

Newer Technologies

• Multiplex PCR panels can simultaneously detect Ehrlichia spp., Anaplasma phagocytophilum, Babesia spp., and Borrelia spp. from whole blood with >97% positive agreement and >98% negative agreement compared to individual assays 5
• These panels can identify coinfections (e.g., B. microti + A. phagocytophilum) that occur in 5–10% of cases 5
• Multiplex serology arrays are under development but not yet standard of care 6

Common Pitfalls to Avoid

Misinterpretation of Serology

• Never diagnose acute tick-borne disease based on a single elevated antibody titer, no matter how high 2
• Never withhold or discontinue treatment because acute-phase serology is negative 1, 2
• IgM antibodies may persist >1 year and have lower specificity than IgG; do not rely on IgM alone 2

Timing Errors

• Collecting convalescent specimen too early (<2 weeks) will miss seroconversion 2
• Sending acute and convalescent specimens to different laboratories introduces inter-assay variation that can obscure true titer changes 2

Overlooking Coinfections

• Ticks can transmit multiple pathogens simultaneously; consider testing for Babesia and Anaplasma in patients with confirmed Lyme disease, especially if symptoms are severe or atypical 3, 5